The gene-editing tool has been used in a trial to enhance the blood cells of two patients with cancer, according to NPR.
No comments yet. Be the first to comment!
More from FoundryBase MIT Technology Review
Know a great resource? Login to add your own!
No comments yet. Be the first to comment!